Nutraceutical News and Research

RSS

Nutraceutical, a portmanteau the words “nutrition” and “pharmaceutical”, is a food or food product that provides health and medical benefits, including the prevention and treatment of disease.

Neutra working to help end staph infections in locker rooms

With football season now in full swing, a dangerous, highly resistant strain of staph infections is plaguing locker rooms across the country, potentially costing organizations such as the NFL and NCAA millions of dollars. Neutra Corp., a growing provider of all-natural wellness solutions, is working to help end the costly epidemic.

17 Oct 2013

Lundbeck, Otsuka to continue development of Lu AE58054 compound for Alzheimer's disease

H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. announced today the continuation of the development program of Lu AE58054 for the treatment of Alzheimer's disease, initiating the first out of four phase III clinical trials with the compound.

10 Oct 2013

Innovative packaging design aids convergence in the pharmaceutical industry

PCI, a global supplier of pharmaceutical commercial packaging solutions and clinical trials services, announces the availability of a white paper detailing how it’s innovative packaging design aids convergence in the pharmaceutical industry.

30 Sep 2013

Redd Remedies earns Better Nutrition Magazine's Best of Supplements Award for Gouch!

Redd Remedies, a leading provider of natural, condition-specific, health and wellness supplements, is this year's recipient of Better Nutrition Magazine's Best of Supplements Award with its all-natural, gluten-free Gouch!.

25 Sep 2013

XYMOGEN announces 2013-2014 seminar series, The Metabolic Nexus

Orlando-based nutraceutical company XYMOGEN has announced a 2013-2014 seminar series, The Metabolic Nexus. The event series, which features presentations from healthcare industry pioneers, aims to bridge the knowledge gap between patients and healthcare professionals.

31 Aug 2013

NTRR announces first phase of development on horticultural post-production system

As part of an ambitious strategy to gain market share in a medical marijuana (MMJ) sector forecast to reach $6 billion over the next five years, Neutra Corp. (OTCBB: NTRR) announced today that the first phase of development is now underway on a horticultural post-production system that could soon revolutionize the time and care needed to deliver medicinal cannabis to patients.

13 Aug 2013

Cyanotech announces first quarter financial results of fiscal year 2014

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the first quarter of fiscal year 2014, ended June 30, 2013.

12 Aug 2013

Trace substance in sugar improves muscle regeneration in mouse model with muscular dystrophy

A trace substance in caramelized sugar, when purified and given in appropriate doses, improves muscle regeneration in a mouse model of Duchenne muscular dystrophy. The findings are published today, Aug. 1, in the journal Skeletal Muscle.

2 Aug 2013

FMC acquires all shares of Epax for $345 million

FMC Corporation today announced that it has acquired all of the shares of Epax Nutra Holding III AS (Norway) and Epax UK Holding III AS (United Kingdom) (together, "Epax"), a leading manufacturer of high purity, premium grade Omega-3 fatty acid concentrates that are used in nutraceuticals, pharmaceuticals and food.

24 Jul 2013

Study shows flavonoid-based nutritional supplements can affect endocrine system

Plant-based diets are healthy. Plants are high in flavonoids. So flavonoids are healthy. At least that's the reasoning of many manufacturers of flavonoid-based nutritional supplements.

16 Jul 2013

Hemp signs distribution agreement with CleanPath for new memory enhancing nutraceutical

Hemp, Inc. announces its first $200,000 sale after inking an exclusive agreement with CleanPath Resources Corp. This agreement is for CleanPath to distribute Hemp, Inc.'s life-changing nutraceutical, "Focus", which is designed to support "Clearer Thinking" and "Improve Memory".

8 Jul 2013

Neutra finalizes LOI with exciting new partner

Neutra Corp., a rapidly-growing provider of all-natural wellness solutions, announced today it has finalized a letter of intent (LOI) with an exciting new partner to grab a share of the exploding $1.7 billion medical marijuana (MMJ) industry.

24 Jun 2013

3Care Therapeutics releases simplified nutritional program to improve patients' health

3Care Therapeutics, a manufacturer of nutritional supplements for treating common chronic health problems, announces the release of the 3Care BioSystems Program, a simplified nutritional program that helps practitioners improve patients' health and achieve thriving nutrition practices. The Program is administered via a free, easy-to-use software application; and unlike more complicated therapeutic lifestyle change programs, the 3Care Program encourages improved health outcomes through better patient compliance.

11 Jun 2013

Neutra's MMJ subsidiary forms joint venture to market, develop cannabis delivery systems

In a major step forward in its plans to deliver healthier, more effective innovations to the fast-growing medical marijuana industry in the U.S., Neutra Corp. announced today that its MMJ subsidiary, Cannabis Technologies, Inc., has formed a new joint venture with Field of View Technologies, LLC, to market and develop breakthrough cannabis delivery systems.

5 Jun 2013

Frutarom reports increased demand for natural ingredient targeting urinary incontinence in adults

Frutarom Health, Switzerland, reports increased demand for Go-Less, its natural ingredient targeting urinary incontinence in adults.

28 May 2013

Scientists design 'fishing' technique to show health benefits of foods

New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death.

21 May 2013

FDA accepts Otsuka Pharmaceutical's tolvaptan NDA for priority review

Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration has accepted for priority review the company's new drug application for the potential use of tolvaptan for the treatment of autosomal dominant polycystic kidney disease.

15 Apr 2013

Lundbeck, Otsuka reach agreement to develop and commercialize Lu AE58054

H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. today announced a license and development agreement for Lu AE58054, a selective 5HT6 receptor antagonist currently in development for the treatment of Alzheimer's disease.

26 Mar 2013

Soybeans can prevent cancer

Soybean meal is a bi-product following oil extraction from soybean seeds. It is rich in protein, which usually makes up around 40% of the nutritional components of the seeds and dependent on the line, and can also contain high oleic acid (a monounsaturated omega-9 fatty acid).

21 Mar 2013

dailyRx News Network expands Total Patient Engagement solution

The dailyRx News Network, a leading digital publisher of health news, announced today that its Total Patient Engagement solution has been expanded and enhanced to include dailyRx-created video health news.

4 Mar 2013